Screening for MGUS in Iceland: A progress report

Just One Year After Its Launch, iStopMM Project Achieves Unprecedented Response

Since its November 2016 launch, nearly 80,000 individuals have volunteered to participate in the IMF Black Swan Research Initiative-supported iStopMM project to screen, treat, or prevent multiple myeloma. “This is the largest myeloma-related study requiring patient participation ever conducted,” says IMF Chairman Dr. Brian Durie. In this week’s blog, he shares the accomplishments of the project’s first year and its future goals. “As the screening results pour in to the iStopMM clinic in Iceland, laboratories and biobank are all up and running…it’s a huge undertaking.” Read the blog.

 

You Did It! You Raised More Than $30,000 This #GivingTuesday

Thanks to your generous support, the IMF received more than $30,000 this #GivingTuesday. Together, we are bringing the myeloma community closer to a cure. We wish you all the best this holiday season and are incredibly grateful for all you do. From our IMF Family to Yours!

 

2018 Open Enrollment for the Affordable Care Act Ends in Two Weeks

You can enroll in or change 2018 marketplace health insurance right now. The 2018 Open Enrollment Period runs from now to December 15, 2017.

Register NOW for the IMF Pre-ASH Satellite Symposium

Register now for the IMF’s Satellite Symposium, on Friday, December 8, 2017, preceding the 59th American Society of Hematology (ASH) Annual Meeting. Listen and interact with international myeloma experts who will share their perspectives on new data, guideline changes, and recommendations for management of patients with multiple myeloma. CME credit is available for participating physicians.

Myeloma Support Group Leaders Travel to Atlanta for ASH 2017

In her first blog about gearing up to attend the 59th annual meeting of the American Society of Hematology (ASH), Support Group Leader Linda Huguelet compares her “journey with myeloma” to Ironman Triathlon competitions. Follow Linda and 11 other IMF myeloma Support Group Leaders as they report live from ASH from December 8, 2017, to December 12, 2017.

Norway Hosts 3 IMF Patient & Family Seminars

More than 500 patients in Norway attended Patient & Family Seminars in Oslo, Trondheim, and Stavanger this November. Dr. Nina Gulbrandsen (Oslo University Hospital) oversaw the seminar in Oslo, and guest speaker Dr. Sundar Jagannath (Mount Sinai Hospital, New York City) shared a presentation titled “Drugs and Treatments for the Future.” Twenty doctors also met at Oslo University Hospital, where Dr. Jagannath discussed the latest therapies in the U.S. Dr. Anders Waage from Trondheim and Dr. Einar Haukås from Stavanger led seminars in their respective cities.

Is it important for a multiple myeloma patient to see a myeloma specialist?

In this week’s video, Dr. Brian G.M. Durie encourages myeloma patients to consult with myeloma specialists at some point during the course of treatment.

This weekly newsletter is supported from funds by donors like you. Donate to continue to make publications like this one possible.

We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology